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Loss of functional retinal ganglion cells (RGC) is an element of retinal degeneration
that is poorly understood. This is in part due to the lack of a reliable and validated
protocol for the isolation of primary RGCs. Here we optimize a feasible, reproducible,
standardized flow cytometry-based protocol for the isolation and enrichment of
homogeneous RGC with the Thy1.2hiCD48negCD15negCD57neg surface phenotype. A
three-step validation process was performed by: (1) genomic profiling of 25-genes
associated with retinal cells; (2) intracellular labeling of homogeneous sorted cells for
the intracellular RGC-markers SNCG, brain-specific homeobox/POU domain protein 3A
(BRN3A), TUJ1, and RNA-binding protein with multiple splicing (RBPMS); and (3) by
applying the methodology on RGC from a mouse model with elevated intraocular
pressure (IOP) and optic nerve damage. Use of primary RGC cultures will allow for future
careful assessment of important cell specific pathways in RGC to provide mechanistic
insights into the declining of visual acuity in aged populations and those suffering from
retinal neurodegenerative diseases.
Keywords: retinal ganglion cell, glaucoma, retinal cells, neurodegeneration, flow cytometry
INTRODUCTION
Millions of the people in the USA suffer from irreversible vision loss that is incited by
retinal ganglion cell (RGC) loss due to retinal neurodegenerative diseases such as diabetic
retinopathy or glaucoma and by age-related changes in neural function or behavior. A
common element in the pathophysiology of both diseases and in the aging population is
the loss or death of RGCs; however the cellular mechanisms underlying their loss remain
unclear. This is in part due to the lack of standardized, reliable protocols to isolate large
numbers of highly enriched RGCs and/or a RGC line for in vitro mechanistic studies (Van
Bergen et al., 2009; Wood et al., 2010). Identifying the genetic basis or cellular mechanisms
causing RGC degeneration would be the first step towards development of efficacious therapies
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to slow or reverse RGC damage, in turn preserving vision. The
lack of a validated RGC population represents a large unmet need
for the vision research community at large.
The isolation and enrichment of primary murine RGCs is
essential for investigating RGC responses to specific therapies
in vitro. A number of challenges have prevented progress
towards the use of a homogeneous primary murine RGC
population. First, a major challenge lies on the scarce number
of RGCs that can be isolated from murine retinae (Dreher
et al., 1985; Williams et al., 1996; Jeon et al., 1998). Second,
current signature markers for the identification of RGCs are
intracellular markers (Surgucheva et al., 2008; Nadal-Nicolás
et al., 2009; Kwong et al., 2010; Rodriguez et al., 2014), impeding
the isolation of viable, metabolically active cells downstream
for in vitro studies. Third, current protocols are lengthy and
have not been standardized for the isolation of primary murine
RGCs from dissociated retinae. Barres et al. (1988) adapted
the immunopanning technique into a two-step process to
purify RGCs. The process includes depletion of macrophages
and endothelial cells, followed by positive selection of cells
responding to anti-thymocyte antigen (Thy1). Recently, Hong
et al. (2012) optimized a similar process that included positive
selection of Thy1+ cells using magnetic beads followed by
cell sorting. Both approaches require lengthy isolations and
their yields are inconsistent. A commercial kit is available for
isolating RGCs from retinae (Pennartz et al., 2010), however,
it has two major limitations. Firstly, the kit is for exclusive
use in rats, yet mice are the primary animal model used in
vision research. Secondly, the specificity of this kit for RGCs
is debatable, as amacrine cells could also be isolated with this
method. In recent years, the use of Dynabeads or flow cytometry
in conjunction with monoclonal antibodies (mAbs; Jackson
et al., 1990) or lectins (Sahagun et al., 1989) have provided
powerful tools to improve the purity of isolated cells. Flow
cytometry, also known as Fluorescence Activated Cell Sorting
(FACS), is a powerful method that analyses cell suspensions and
provides quantitative and qualitative data with a high level of
sensitivity. FACS cellular discrimination is based on physical
properties such as surface area and the internal complexity or
granularity of the cells (Julius et al., 1972). Multi-dimensional
analyses, based upon the expression of proteins on the cell
surface as well as intracellular localization, can be performed by
the combination of mAbs tagged with fluorochromes. Current
FACS-based cell sorting techniques allow for the separation
of up to four different cell populations based on multivariate
properties. Sorted cells can be collected and are viable for
downstream analyses.
In the present study, we developed a novel flow cytometry-
based protocol to generate a homogeneous RGC population from
murine retinae. We employed a highly stringent sort strategy
coupled with qualitative PCR (qPCR) and intracellular staining
with RGC-signaturemarkers to verify the purity and homogeneity
of the enriched population. Our isolation technique provides a
powerful tool for vision research to assist in the understanding
of the molecular pathways and key players in preservation
of RGC function and health to develop novel therapies for
vision loss.
MATERIALS AND METHODS
Dissociation of Murine Retinae
Two hundred C57BL/6J mice between 5–7 weeks of age,
22 BXD66 mice ages 5 weeks (young) and >12 months (old)
were used in this study. All procedures were approved by
the Institutional Animal Care and Use Committee (IACUC)
review board at the University of Tennessee Health Science
Center (UTHSC) and followed the Association for Research
in Vision and Ophthalmology (ARVO) Statements for the
Use of Animals in Ophthalmic and Vision Research, in
addition to the guidelines for laboratory animal experiments
(Institute of Laboratory Animal Resources, Public Health Service
Policy on Humane Care and Use of Laboratory Animals).
Mice were sacrificed by cervical dislocation followed by
enucleation, as previously described (Jiang et al., 2015). Retinae
were dissociated using enzymatic digestion. The resultant cell
suspension was filtered using a Falcon 70 µm nylon strainer (BD
Biosciences, San Jose, CA, USA) followed by centrifugation at
1500 RPM × 5 min at RT. Cells were resuspended in PBS/1%
FBS (Lonza, Walkersville, MD, USA) and kept on ice until ready
for use.
Flow Cytometry Analyses
Cell Surface Labeling
Cell viability was evaluated at the time of retinae cell dissociation.
To ensure we obtain live cells after sorting, we labeled the
cells with Zombie AquaTM (BioLegend, San Diego, CA, USA)
a permeant dye to discriminate between live (negative for dye)
and dead (positive for dye) cells. Live cells were treated with
1.0 µg of anti-CD16/CD32 per 1.0 × 106 cells in 100 µL to
block FcγRII/III (clone 93; BioLegend), which minimizes non-
specific binding of the primary antibodies and in turn inhibits
endocytosis, phagocytosis and antigen presentation due to FcγR
activation. The following primary antibodies were used to detect
surface antigens by incubating the cells on ice for 30 min:
anti-CD90.1 PerCP-Cy5.5 (Thy1.1, clone OX-7, BioLegend,
exhibits no cross-reactivity with CD90.2); anti-CD90.2 Alexa
Fluor-700 (Thy1.2, clone 30-H12, BioLegend, exhibits no cross-
reactivity with CD90.1); anti-CD48 PE-Cy7 (clone HM48-1,
BioLegend, labels monocytes and microglia); anti-CD15 PE
(clone MC-480, BioLegend, labels amacrine cells); and anti-
CD57 (clone VC1.1, Sigma Aldrich, St. Louis, MO, USA also
labels amacrine cells). Because the anti-CD57 antibody was
unconjugated, a Brilliant violet 421-tagged secondary antibody
(Life Technologies, Carlsbad, CA, USA) was used to allow for
sorting.
Sorting Strategy
Cells were enriched by FACS using a BD Biosciences
FACSAriaTM Cell Sorter equipped with 4-lasers (BD Biosciences,
San Jose, CA, USA). In this investigation, we used the 488 nm
blue, the 630 nm red and the 405 nm violet diode lasers.
Dissociated cells were maintained at 4◦C using a temperature
controlled sample injection and collection chamber. At the time
of cell sorting, we used unlabeled murine retinal cells as controls
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and individual samples were labeled with antibodies specific for
different retinal cell surface markers. We used AbCTM Total
Antibody Compensation Bead Kit (Life Technologies) to prepare
single color controls using the manufacturer’s protocol. These
are highly sensitive and efficient antibody capture beads with a
broad multispecies reactivity. To determine the efficiency of the
sort, we performed FACS analysis on a small aliquot from the
eluted sorted cells.
Intracellular Labeling
Dissociated cells labeled as detailed above followed by
1 h fixation at 4◦C using the BD Cytofix/Cytopermr
fixation/permeabilization solution (BD Biosciences) as in
Morales-Tirado et al. (2004, 2010, 2011) and Kasow et al. (2011).
Cells were incubated for 1 h at 4◦C in the following antibodies
that were diluted in BD Perm/Wash (BD Biosciences) buffer:
anti-RNA-Binding Protein With Multiple Splicing (RBPMS;
rabbit polyclonal IgG; Santa Cruz Biotechnology, Santa Cruz,
CA, USA; 1:100 dilution); anti-SNCG (rabbit polyclonal IgG;
GeneTex, 1:100 dilution), Brain-Specific Homeobox/POU
Domain Protein 3A (BRN3A; goat ployclonal IgG; Santa
Cruz Biotechnology; 1:100 dilution); and anti-TUJ1 (mouse
monoclonal IgG2a; Covance; 1:100 dilution). The appropriate
Alexa Fluor 488 tagged secondary antibodies (1:200 dilution;
Invitrogen) were used to allow for data acquisition and analysis.
Cells were kept in PBS/1%FBS on ice until the time of analysis.
Data acquisition was performed on a BD LSRII Flow Cytometer
(BD Biosciences) and analyses were performed using FlowJo
vX10.0.6 (Tree Star, Inc., Ashland, OR, USA). To confirm results
we performed additional data acquisition using the Miltenyi
Biotec MACSQuantr 10 Analyzer (Myltenyi Biotec, San Diego,
CA, USA).
Flow Cytometry and Confocal Microscopy Dual
Analysis
Labeled retinal cells were acquired based on area and aspect
ratio, gating out cell debris and cell aggregates from the analysis
using the Amnisr FlowSightr Imager (EMD Millipore, Amnis
Division, Seattle, WA, USA). Flow cytometry features include a
violet (405 nm, 100 mW), blue (488 nm, 60 mW), red (642 nm,
100mW), and side scatter (SSC; 785 nm, 8mW) lasers. Data were
analyzed in IDEAS Software after compensation of single color
control samples using a compensation matrix. Confocal images
were taken at 20×.
Gene Analyses
RNA Isolation and cDNA Synthesis and
Pre-Amplification of cDNA Template
RNA from 5.0 × 105 sorted Live Thy1.2+
CD48negCD15negCD57neg cells was extracted following the
Qiagenr miRNeasy Mini Kit (Qiagen, Valencia, CA, USA)
manufacturer’s specifications. RNA concentration was assessed
using a Nanodrop Spectophotometer (Nanodrop, Wilmington,
DE, USA). cDNA was synthesized from RNA using the
SuperScriptr VILOTM cDNA Synthesis Kit (Life Technologies).
Following the manufacturer’s instructions, we used 100 ng of
RNA for each reaction. Briefly, the pre- amplification reaction
mixture was prepared to discriminate among different retinal
cells (Table 1) using cDNA, TaqManr PreAmp Master Mix
and the pooled primer mix listed in Table 2. Pre-amplification:
the enzyme activation step was carried out at 95◦C for 10 min,
followed by 14 cycles at 95◦C for 15 s followed by 60◦C for 4 min.
Subsequently, the pre-amplified cDNA was diluted 1:10 in Tris
EDTA buffer and was kept at−20◦C until ready for use. The pre-
amplification of cDNA step was crucial to increase the sensitivity
of detection for downstream quantification using qPCR. As part
of our stringent validation and confirmation techniques, we used
a series of gene targets that are specific for different retinal cell
populations, including a housekeeping gene (Hprt). The primers
TABLE 1 | Genes used in gene expression analyses as part of the
validation of our RGC enrichment protocol.
Retinal cell type Genes expressed by retinal cell type
Retinal ganglion cell Pou4f1; Rbpms; Sncg; Tubb3; Chrma6; Rbfox3; Nef-H
Amacrine Gad2; Fut4; Calb2; Pvalb; Slc6a9; Pcp4; Vip; Thy1
Astrocytes Aqp4; Prdx6; Gfap; Slc1a3; Pax2
Müller ApoE; Abca8a; Vim; Aldh1a1
Bipolar Pkcα; Pcp4; Rcvrn; Slc1a2
Horizontal Rcvrn; Prox1; Ntrk1; Lhx1, Lim2, Calb2
Photoreceptors Nrl; Rom-1; Crx; Pxph2; Arr3
(Cone and Rod)
Retinal pigment Cd68; Rpe65
Epithelial cells
Housekeeping gene Hprt
TABLE 2 | List of primers used for gene expression analyses as a
component of the validation of our RGC enrichment protocol.
Gene symbol Taqmanr Gene expression
assays (Primers)
Abca8a Mm00462440_m1
Aldh1al Mm00657317_m1
Aqp4 Mm00802131_m1
Calb2 Mm00801461_m1
Cd68 Mm03047340_m1
Gad2 Mm00484623_m1
Hprt Mm01545399_m1
Lhx1 Mm01297482_m1
Lim2 Mm00624623_m1
Nrl Mm00476550_m1
Ntrk1 Mm01219406_m1
Pcp4 Mm00500973_m1
Pov4f1 Mm02343791_m1
Prdx6 Mm00725435_s1
Prkca Mm00440858_m1
Prox1 Mm00435969_m1
Pvalb Mm00443100_m1
Rbpms Mm02343791_m1
Rom1 Mm00436364_g1
Rpe65 Mm00504133_m1
Slc1a3 Mm00600697_m1
Slc6a9 Mm00433662_m1
Sncg Mm00488345_m1
Tubb3 Mm00727586_s1
Vim Mm01333430_m1
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that were used for the pre-amplification step are listed in the
Table 2.
qPCR Analysis Amplification Efficiency Test
We determined the primer efficiency and amplification
efficiency by the absolute quantification method using a Roche
LightCyclerr 480 Instrument and Version 1.5.0 Software
(Roche, Indianapolis, IN, USA). Pre-amplified cDNA was
serially diluted to a range of concentration (1, 1:10, 1:100,
1:1000). This comparison ensured that the pre-amplification
process amplified genes with a wide variation of abundance.
The comparative threshold (CT) values were plotted against the
log concentration qPCR product and the slope was calculated.
The closer the slope is to −3.33, the closer the amplification
efficiency is to the 100% ideal, which indicates that there is
a doubling of product per cycle. In addition, we performed
linear regression analysis to show the correlation between gene
expression measurements from our samples for the primers
we validated, and a standard curve. In this study, we used CT
values ranging from 15 to 30 in our assays. Three biological
replicates were evaluated and the CT values were normalized
to the endogenous gene (Hprt) control and compared to the
CT values obtained from the pre-amplifed cDNA from murine,
non-sorted, retinal cells.
qPCR Reaction
For qPCR reaction we prepared a final volume of 10 µL PCR
reaction mixture using TaqManr Universal Master Mix, diluted
pre-amplified cDNA, primers (Table 2) and Nuclease Free water.
Plates were analyzed on a Roche LightCyclerr 480. Instrument
conditions included first a hold step of 50◦C for 2 min followed
by 95◦C for 10 min. Next, we performed 40 cycles of 95◦C for
15 s followed by 60◦ for 1 min. All measurements were made in
replicates of three. Relative quantification was performed using
CT after determining the values of CT for the reference gene
(housekeeping) and the target genes in each sample. The relative
fold change (Rq) was calculated using the following formula:
Rq = 2−∆CT , where ∆CT = CT target gene − CT reference
gene. Data are presented as mean ± SEM. Differences between
two means were assessed with ANOVA and Tukey’s post hoc
test (PRISM, Graph Pad, La Jolla, CA, USA). Differences were
considered significant at p< 0.05.
Immunohistochemistry
Murine retinal sections embedded in low melting point agarose
were prepared following our published methods (Nookala et al.,
2010). Briefly, tissue sections were blocked with 10% goat
serum and permeabilized with 2.5% Triton X-100. The following
primary antibodies were used per manufacturers conditions:
RBPMS (rabbit polyclonal IgG, Santa Cruz Biotechnology,
1:100 dilution); anti- γ-synuclein (SNCG, rabbit polyclonal IgG,
GeneTex, 1:100 dilution); anti-BRN3A (goat polyclonal IgG,
Santa Cruz Biotechnology, 1:10 dilution); anti-Neuronal Class
III β-Tubulin (TUJ1, mouse monoclonal IgG2a, Covance,
Princeton, NJ; 1:100 dilution); anti-HNK-1/N-CAM (CD57,
Clone VC1.1, mouse monoclonal IgM, 1:10 Dilution); and
CD15 (Clone:MC-480, mouse monoclonal IgM, BioLegend,
1:25 dilution). The appropriate Alexa Fluor-tagged secondary
antibodies (Invitrogen, Waltham, MA; 1:200 dilution) and
TO-PRO-3 iodide (Invitrogen; 1:4000 dilution) were used to
indicate the location of the antigens of interest and nuclei,
respectively. Sections were viewed and images were obtained
using a Nikon C1 (Nikon, NY, USA) confocal microscope within
the Imaging Core Facility in the Hamilton Eye Institute. All
microscope settings, including laser levels and gain, were held
constant to allow for relative comparisons of signal intensity
within and between experiments.
Immunofluorescence
Live Thy1.2+ CD48negCD15negCD57neg sorted cells (50,000
cells) were washed once with Hanks Balanced Salt Solution
(HBSS) in followed by centrifugation at 1200 RPM × 5 min
at RT. Cells were labeled with SYTOr59 (100 nM) for
10 min in a HBSS at 37◦C followed by multiple washes with
HBSS for 5 min each. Cells were plated on a glass bottom
microwell dish (35 mm petri dish, 14 mm microwell; MatTek
Corporation, Ashland, MA, USA) and sealed with coverslip.
Analysis performed using a Nikon C1 (Nikon, NY, USA)
confocal microscope within the Imaging Core Facility in the
Hamilton Eye Institute.
Optic Nerve Processing, Imaging and
Counting
Eyes along with optic nerves were enucleated from mice
immediately after euthanasia. Optic nerves were cut close
to the globe and were fixed in 0.8% paraformaldehyde and
1.22% glutaraldehyde in 0.08 M phosphate buffer. They were
subsequently rinsed in buffer and post-fixed in 1% osmium
tetroxide. After dehydration, the specimens were embedded
in Epon 812 plastic. Sections (0.8 µm thick) were cut on
an ultramicrotome (Reichert-Jung Ultracut E Ultramicrotome),
stained with p-phenylenediamine (PPD) for 30 min. Digital
images were taken using 10× and 4× objectives using a
MicroFire digital camera (Optronicsr, Goleta, CA, USA)
mounted onto a Nikon Eclipse E800 light microscope (Nikon).
Multiple contiguous photomicrographs were taken at 60×
magnification to provide a continuous representation across
the optic nerve. A scale of optic nerve damage similar to
that used by Clark et al. was used to assign a numeric
value to the appearance of the nerve (David Cantu-Crouch,
Iok-Hou Pang, Mitchell D. McCartney, Abbot F. Clark;
unpublished protocol). The numeric value is based upon the
presence/absence of darkly stained axoplasm and presence of
gliotic scars.
Intraocular Pressure Measurements
Intraocular pressure (IOP) was measured using the
induction–impact tonometer (Tonolab tonometer, Colonial
Medical Supply, Franconia, NH, USA) for rodents according to
the manufacturer’s recommended procedures. When measuring
IOP, the tonometer was fixed in a vertical position to a support
stand by means of clamps. The mouse was gently restrained by
hand on an adjustable stand, and the eye was oriented in such
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FIGURE 1 | Lack of specificity of current retinal ganglion cells (RGC) isolation methods. (A) Far left panel: Pseudocolor plots were gated on live nucleated
cells based on forward scatter (FSC) and side scatter (SSC) profiles. Based upon these characteristics, 84.6% of the cells were live after retinal dissociation. Mid left
panel: A negligible number of live retinal cells were Thy1.1+, whereas 53.9% were Thy1.2+, demonstrating that in mouse Thy1.2 is the preferred surface marker. Mid
right panel: The majority of the Thy1.2+ cells (88%) were CD48neg. Far right panel: There was no significant difference in the percent of live Thy1.2+ and Live Thy1.2+
CD48neg cells demonstrating that the addition of CD48 as a negative selection marker is insufficient to further enrich for RGCs. (B) Only 60% of LiveThy1.2+
CD48neg are SNCG+ indicating that many contaminating cell types remain in the LiveThy1.2+ CD48neg cell population. Gray histogram represents control and black
line represents experimental sample. (C) Identification of Thy1.2+ CD48neg cells using qualitative real time PCR analysis. The expression levels of a panel of 25 genes
expressed by various retinal cell types—amacrine, Müller, bipolar, horizontal, photoreceptor and retinal pigment epithelial cells—in Thy1.2+ CD48neg cells were
normalized to the levels present in unsorted total retinal cells. The Thy1.2+ CD48neg population was contaminated with all other retinal cell types. Target gene
expression levels are presented as Log2 fold change based on the comparative threshold (CT) calculation using Hprt as a housekeeping gene and water as negative
control. Mean ± SEM; n = 3 biological replicates were performed in triplicate.
a way that a distance of 1–4 mm was maintained between from
the tip the probe to the cornea of the eye. Six consecutive IOP
readings were averaged. IOP readings obtained with Tonolab
have been shown to be accurate and reproducible in various
mouse strains, including DBA/2J.
RESULTS
The Thy1+ CD48neg Surface Phenotype Is
not Sufficient to Identify Murine RGCs
Murine retinal cells express two distinct isoforms of
Thy1—Thy1.1 and Thy1.2 (Reif and Allen, 1964; Watanabe
et al., 1981; Haeryfar and Hoskin, 2004). We compared the
binding of Thy1.1 and Thy1.2 to dissociated murine retinal
cells and show the majority of murine retinal cells exhibit
immunoreactivity against Thy1.2 but not Thy1.1 (Figure 1A,
Thy1.2+ at 53.9% vs. Thy1.1+ at 1.7%). Current RGC isolation
techniques use selection based on Thy1-positivity and CD48-
negativity by antibody-capture (Barres et al., 1988; Hong et al.,
2012) or magnetic cell isolation (Sahagun et al., 1989; Pennartz
et al., 2010). Our data demonstrate that a small percent of
Thy1.2+ cells were also immunopositive for CD48 (11.2%)
and that inclusion of CD48 as a negative selection marker
did not significantly decrease the number of Thy1.2+ cells
(Figure 1A, right panel). To determine if the Thy1.2+ CD48neg
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cells were RGCs, we probed the cells for the expression of
the RGC signature marker γ-synuclein (SNCG). Consistently,
we found that a large proportion of Thy1.2+ CD48neg cells
were not SNCG+. Figure 1B illustrates that 60% of Live
Thy1.2+ CD48neg cells were positive for SNCG, suggesting
that there is ∼40% contamination by non-SNCG+ cell types.
To address which non-RGC cell types are present within the
Thy1.2+ CD48negSNCGneg phenotype, we performed qPCR
analysis on the sorted cells. Results shown in Figure 1C
reveal the degree of heterogeneity of the enriched RGCs
using only Thy1.2 and CD48 as surface markers. Specifically,
Thy1.2+ CD48neg cells expressed genes associated with multiple
retinal cells, including amacrine, Müller, bipolar, horizontal,
photoreceptors and retinal pigment epithelial cells. Table 1
lists the specific genes associated with the various cell types.
Our data demonstrates that selection based solely on Thy1
and CD48 expression is insufficient to isolate highly enriched
RGCs.
Confirmation of Additional Surface
Markers to be Used as Negative Selectors
and Intracellular RGC Markers
We used immunohistochemistry (IHC) to determine the
retinal localization patterns of other surface markers that
were expressed by contaminating cells. CD15 has been
described as a marker of retinal interneurons including
amacrine and bipolar cells (Jakobs et al., 2003), while CD57
has been shown to label glial cells and photoreceptors
(Uusitalo et al., 2003). Our data demonstrate that CD15
(Figure 2A) is localized in the interface between the inner
nuclear layer (INL) and inner plexiform layer (IPL) and
in the proximal INL (arrows), where amacrine cells are
located. Occasional CD15+ cells were observed in the ganglion
cell layer (GCL), which are most likely displaced amacrine
cells (arrows). CD57 immunoreactivity (Figure 2B) was
abundant in the outer plexiform layer (OPL) and in a
radial pattern through the INL. Punctate staining was also
present in the GCL, which are likely astrocytes or displaced
amacrine cells. Collectively, these results show that these
surface markers—CD15 and CD57—can be used as negative
selectors to remove non-RGCs from the Thy1.2+ CD48neg cell
population.
To verify that the commonly accepted RGC intracellular
markers are specific for RGCs (Jackson et al., 1990; Surgucheva
et al., 2008; Nadal-Nicolás et al., 2009; Kwong et al., 2010), we
labeled murine retinal sections with antibodies against SNCG,
BRN3A (Pouf4l), TUJ1 [neuron-specific class III beta tubulin
(Tubb3)] and RBPMS. SNCG showed abundant expression
in the GCL (Figure 2C). Abundant BRN3A (Figure 2D)
labeling was observed in the GCL. However, multiple cells
in the INL that border the IPL are also immunopositive
for BRN3A. Based upon their location, they are likely
amacrine cells. TUJ1 (Figure 2E) was very abundant in the
GCL and in radial labeling patterns throughout the retina
that extend up to the ONL. Lastly, RBPMS was highly
expressed by cells in the GCL (Figure 2F) and a small
subpopulation of cells in the INL (arrow). Collectively, these
data demonstrate that SNCG-, BRN3A-, TUJ1- and RBPMS-
positive cells are present in the GCL and can be used
to validate the identity of the cells that we isolate using
our array of cell surface markers. Even though BRN3A
and RBPMS also label a small subset of (likely) amacrine
cells, we are confident that requiring all enriched RGCs to
express all four RGC markers will yield a nearly pure RGC
population.
Live Thy1.2+ CD48negCD15negCD57neg
RGC Express All Signature Intracellular
Markers SNGC, BRN3A, TUJ1 and RBPMS
Our expanded cell sorting strategy is presented in Figure 3A.
Because Thy1.2+ CD48neg cells expressed many markers
associated with retinal cells other than RGCs, we added
additional surface markers—CD15 and CD57—to our sorting
strategy to remove these contaminating cells. Our methodology
included the negative selection of these cell surface markers
to enrich for naïve RGCs that could be used in downstream
analyses. Collectively, we were targeting the removal of
monocytes, as well as glial, amacrine and photoreceptor
cells. Prior to cell surface labeling, we added purified mouse
anti-CD16/32 antibody to block FcγRII/III, thus reducing
false positive immunoreactivity (Unkeless et al., 1979; Balogh
et al., 2002). Our flow cytometry-based cell sorting validation
studies included examination of pre- (Figure 3B) and post-
sorted cells (Figure 3C) to confirm that the post-sorted
cells that were isolated using cell surface markers expressed
all four RGC intracellular markers: SNCG, BRN3A, TUJ1,
and RBPMS. Consistently, we observed 99–100% positivity
for all of the intracellular markers in the post-sorted cells,
demonstrating the isolated cells were very highly enriched,
if not pure RGCs. We ensured consistency of our results
across multiple systems using two other cytometer systems, the
MACSQuantr Analyzer 10 and the FlowSightr. Because our
results were reproducible across three different flow platforms,
we are confident that our novel method is standardized
(Supplementary Figures 1 and 2).
Using confocal microscopy, we investigated the
morphological appearance of the sorted cells. Live Thy1.2+
CD48negCD15negCD57neg cells were stained with SYTOr 59 dye
showing nuclear integrity. Cells showed bright blue fluorescence
and strong intracellular staining (Supplementary Figure 3).
This result confirms Live Thy1.2+ CD48negCD15negCD57neg
sorted cells show the morphology associated with RGC.
Validation of the Enriched RGC Population
by qPCR Analyses
To determine if the enriched RGC population isolated using
our improved strategy contained contaminants from other
retinal cell populations, we measured mRNA levels by qPCR
analysis using the same primers that we used on Thy1.2+
CD48neg cells (Figure 1C). Our method is presented in
Figure 4A. Using the absolute quantification method, we
determined the optimal concentration of pre-amplified
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FIGURE 2 | Immunohistochemical localization of surface antigens and RGC markers used in our RGC sorting protocol. Cellular localization of the surface
proteins CD15 and CD57, as well as the intracellular proteins SNCG, BRN3A, TUJ1 and RBPMS in retinae from C57BL/6J mice. Sections from C57BL/6J mouse
retinae were labeled with antibodies against (A) CD15, (B) CD57, (C) SNCG, (D) BRN3A, (E) TUJ1, and (F) RBPMS. TO-PRO-3 iodide staining labeled nuclei of all
retinal cells (blue). Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer.
Scale bar: 10 µm.
samples that would be suitable for our validation step and
calculated the efficiency of amplification (Figure 4B). qPCR
analyses (Figure 4C) shows that the highly enriched RGC
population had a many fold increase in the expression of
all four RGC intracellular markers: Sncg, Pouf4l, Tubb3
and Rbpms. As expected, genes found in other retinal cells
were expressed at significantly lower levels than in unsorted
retinal cells. Moreover, our improved sorting methodology
removed the contaminating retinal cell types that were present
in the Thy1.2+ CD48neg cells (compare Figures 1C, 4C).
These mRNA analyses further validated our RGC enrichment
strategy.
Highly Enriched RGCs can be Isolated
from A Mouse Model with Elevated IOP
and Optic Nerve Damage
We sought to apply our improved RGC isolation methodology
on a retinal degenerative disease model. Members of our
research group have analyzed a family of over 100 BXD
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FIGURE 3 | Optimized fluorescent activated cell sorting (FACS)-based cell sorting strategy. (A) Schematic representation of RGC isolation by flow
cytometry using multiple surface markers. Step 1: Cells were labeled with Zombie AquaTM for live/dead cell analysis followed by step 2: blocking of FcγRII/III
(mouse anti-CD16/32) to minimize non-specific labeling. Step 3: Cell surface labeling was performed using the following antibody cocktail: anti-mouse anti-CD90.2
Alexa Fluor 700; anti-CD48 PE-Cy7; anti-CD15 PE and anti-CD57 Brilliant Violet 421 to yield LiveThy1.2+ CD48negCD15negCD57neg cells. Single labeled
fluorochrome-beads were used as controls. (B) Surface marker expression of pre-sorted retinal cells. Far left panel: Live retinal cells show two distinct
populations of Thy1.2 (Thy1.2hi and Thy1.2low) based upon expression levels per cell. Right panels: Representative FACS plots show the expression of surface
markers used for negative selection—CD48, CD15, CD57—in pre-sorted Thy1.2hi and Thy1.2low retinal cells. Labeled retinal cells were sorted for
Thy1.2hiCD48negCD15negCD57neg population. Selection for sorting included the positive selection of Thy1.2hi (36%). This population was further selected for
CD48neg (3%), followed by CD15neg (20%) and CD57neg (36%). (C) Purity of the sorted RGCs based on the surface marker and intracellular RGC markers. Far left
panel: LiveThy1.2+ CD48negCD15negCD57neg cells show expression of Thy1.2+ (95%). Top right panels present representative FACS plots show the negligible
expression of surface markers in sorted LiveThy1.2+ CD48negCD15negCD57neg cells, demonstrating the efficiency of the sort. Lower row panels show representative
FACS plots of the expression of intracellular RGC markers in LiveThy1.2+ CD48negCD15negCD57neg cells. Ninety nine to hundred precentage of all cells express
SNCG, BRN3A, TUJ1 and RBPMS, all well characterized RGC markers. The sum of gated and non-gated cells in each histogram totals 100%. This new sorting
method (Thy1.2hiCD48negCD15negCD57neg) shows improvement over the previously used methodology (LiveThy1.2+ CD48neg) using additional surface markers.
Grey indicates isotype controls, colored solid lines indicates experimental samples.
(Peirce et al., 2004) murine strains and their parental
strains—C57BL/6J and DBA/2J—at five different age cohorts
to determine which strains had the phenotype of optic
nerve damage and elevated IOP. Both of these phenotypes
are associated with retinal degeneration in glaucoma. Our
examination revealed that the BXD66 strain had both elevated
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FIGURE 4 | Validation of our improved protocol for the enrichment of RGCs. (A) Schematic representation of our validation analyses of Live Thy1.2+
CD48negCD15negCD57neg sorted cells. (B) Amplification and standard curves to evaluate primer efficiency. Left panel: amplification curves of the 10-fold dilution
series for all the primers. Right panel: Standard curves depicting CT plotted against the log of the starting quantity of template for each dilution. The efficiency of the
all PCR reactions was between 90–100% (−3.6 ≥ slope ≥ −3.3). All samples were prepared and analyzed in triplicate. (C) Validation of Live Thy1.2+
CD48negCD15negCD57neg cells using qPCR analyses. Graph depicts expression of different retinal cells markers in Live Thy1.2+ CD48negCD15negCD57neg that were
normalized to the mRNA expression measured in total primary murine retinal cells. Genes associated with RGCs—Sncg, Pouf41, Tubb3 and Rbpms—showed
increased gene expression compared to non-RGC associated genes. Target gene expression levels are presented as Log2 fold change based on CT calculation
using Hprt as housekeeping gene and water as negative control. Mean ± SEM; n = 3 biological replicates were performed in triplicate.
IOP and higher optic nerve damage compared to both C57BL/6J
and DBA/2J parental strains of mice (Figure 5A). In addition,
the optic nerves of old BXD66 mice had an increase in axon
damage and glial scarring compared to young C57L/6J and
BXD66 mice. Figure 5B depicts representative micrographs
showing optic nerve damage.
To determine if our RGC protocol was valid using retinae
with damaged RGCs, we applied our optimized and validated
enrichment strategy on retinae obtained from young and old
BXD66 mice. We compared two different ages to investigate
if our enrichment protocol could be used on mice with
compromised RGCs and if the efficiency of the strategy was age
dependent. We first compared the cellularity of retinal cells and
the percentage of live cells between the two ages of mice. We
consistently found a marked reduction in the number of live
retinal cells between BXD66 old (>12 months old) and young
(5 weeks old) mice (Figure 5E; live cells young vs. old: 80%
vs. 48%). It is worth noting that the percentage of live cells
isolated from young pre-degenerative BXD66 mice (5 weeks
old) is comparable to that obtained from young C57BL/6J
(5–7 weeks old) mice (compare to Figure 1A). Selecting for
the phenotype Live Thy1.2+ CD48negCD15negCD57neg, enriched
RGCs (Figure 5C) were examined for the presence of the same
signature intracellular RGC markers that we used throughout
this investigation. Similar to that found in C57BL/6J mice,
the majority of the enriched cells from BXD66 mice are
immunoreactive toward the four intracellular RGC markers
(Figure 5D). However, we observed a slight reduction in TUJ1
in BXD66 young and old mice compared to the C57BL/6J
parental line, which may be indicative of RGC damage in
this model. When comparing the total number of retinal
cells (obtained from retinae of young and old C57BL/6J and
BXD66 mice) with those of the phenotype Live Thy1.2+
CD48negCD15negCD57neg, we found similar patterns of changes
(compare both panels in Figure 5F).Within a strain, retinae from
old mice had fewer live retinal cells than young mice. In addition,
retinae from BXD66 mice had a reduced number of retinal
cells compared to age-matched C57BL/6J mice (Figure 5F).
Moreover, old C57BL/6J mice had a lower percentage of
Thy1.2hiCD48negCD15negCD57neg retinal cells compared to
youngmice (0.9%± 0.3 in youngmice compared to 0.5%± 0.3 in
old mice, p = 0.041, Figure 5F). Retinae from young BXD66 mice
also had a higher, but not significantly different, percentage of
Thy1.2hiCD48negCD15negCD57neg cells compared to old BXD66
mice (0.4% ± 0.3 in young mice compared to 0.2% ± 0.2 in
old mice, p = 0.177). Lastly, there was a significant reduction in
the percentage of Live Thy1.2hiCD48negCD15negCD57neg cells in
retinae from young BXD66 mice compared to young C57BL/6J
(0.9% ± 0.3 in C57BL/6J mice compared to 0.4% ± 0.3 in
BXD66 mice, p = 0.024). Collectively, our data show that our
improved RGC enrichment protocol is also effective on retinae
from old mice with no retinal degeneration (C57BL/6J) and
in mice with a phenotype of elevated IOP and RGC damage
(BXD66).
DISCUSSION
Evidence suggests the vulnerability of the ganglion cells
to aging (Jackson and Owsley, 2003; Calkins, 2013). Age-
related degeneration contributes to decrease in visual function,
contributing to impairment and reduction in health-related
quality of life. The physiological function of the ganglion
cells in aging is affected by a myriad of factors including
changes in morphology, anatomy and at the subcellular level
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FIGURE 5 | Fewer RGCs are harvested from mice with documented elevated intraocular pressure (IOP) and RGC damage. (A) Peak IOP and optic nerve
damage distributions for C57BL/6J, DBA/2J and BXD66 mice. BXD66 mice had significantly higher peak IOP (blue bars) and optic nerve damage (pink bars)
compared to C57BL/6J mice (∗∗p < 0.005 between B6 and BXD66 IOP values; ##p < 0.005 between B6 and BXD66 optic nerve damage grade). Mean ± SEM;
n = 4 per group. (B) Representative p-phenylenediamine (PPD)-stained optic nerve cross-sections from C57BL/6J (young: 5–7 weeks old), BXD66 (young: 5 weeks
old), and BXD66 (>12 months old) mice. Both young C57BL/6J and BXD66 mice had a low degree of damage. In contrast, optic nerves from old BXD66 mice
presented with disorganized axon bundles, increased glial scarring and multiple dead/dying axons. Scale bar = 10 µm. (C) Characterization of enriched RGCs from
young and old BXD66 mice obtained through our improved flow sorting method. Representative histograms show comparison of surface expression of Thy1.2,
CD48, CD15 and CD57 in total retinal cells of young vs. old BXD66 mice. Top panel: In BXD66 young mice, live retinal cells have the following abundance levels:
(Continued)
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FIGURE 5 | Continued
Thy1.2 (56%), CD48 (63%), CD15 (81%) and CD57 (66%). Bottom panel: In
BXD66 old mice, live retinal cells have the following abundance levels: Thy1.2
(41%), CD48 (77%), CD15 (80%) and CD57 (50%). Gray histogram indicates
isotype controls, black solid lines indicates antibody labeling. (D) Relative
purity of sorted RGCs based upon surface marker selection and intracellular
RGC markers. Representative histograms show comparison of intracellular
expression of RGC markers SNCG, BRN3A, TUJ1 and RBPMS in Live
Thy1.2+ CD48negCD15negCD57neg cells of young and old BXD66 mice. Top
panel: In BXD66 young mice have the following abundance levels: SNCG
(100%), BRN3A (100%), TUJ1 (90%) and RBPMS (100%). Bottom panel: In
BXD66 old mice have the following abundance levels: SNCG (98%), BRN3A
(100%), TUJ1 (95%) and RBPMS (100%). Gray histogram indicates isotype
controls, black solid lines indicates antibody labeling. (E) Number of cells per
retina obtained from dissociated retinae from young and old mice.
(F) Percentage of Live Thy1.2+ CD48negCD15negCD57neg cells in retinae from
C57BL/6J (young and old) and BXD66 (young and old) mice. ∗∗p < 0.005;
∗p < 0.05 compared to young C57BL/6J mice. Mean ± SEM; n = 3 per
group.
(Spear, 1993; Samuel et al., 2011; Calkins, 2013). Similarly,
several retinal neurodegenerative diseases have the common
factor of loss of ganglion cells and their axons (Garcia-Valenzuela
et al., 1995; Weber et al., 1998; Osborne et al., 1999; Morgan
et al., 2000; van Dijk et al., 2009, 2010). The understanding
of the mechanisms underlying these processes is limited by
the lack of a simple in vitro system with which to study
RGC function. This is in part is due to the scarce number
of RGCs and the heterogeneity present among the current
cellular enrichment protocols. The use of antibody-dependent
plate adhesion, or immunopanning, originated more than 35
years ago when it was used for the enrichment of immune cells.
Barres et al. (1988) utilized the immunopanning system wherein
they used Thy1 and CD48 to isolate RGCs. They demonstrate
the following three points: (1) Thy1 is not an exclusive marker
of murine or rat RGCs, as other Thy1+ retinal cells do not
show the morphology and/or electrophysiological characteristics
of RGCs; (2) there is variation in the expression of Thy1
positivity among RGCs; and (3) this assay only produced a
95% efficiency based on Thy1 expression. This classical study
allowed for the first use of immune techniques in the field
of neuroscience. Prior to the publishing of this methodology,
RGC isolation was based on density gradient centrifugation
with varying yield degrees (Kornguth et al., 1981; Beale et al.,
1983; Sarthy et al., 1983). Although inexpensive and rapid, a
major drawback of Barres’s methodology was that it required
the retrograde labeling of fast blue into both superior collicular
and brachia 48 h prior to retinal dissection. Shoge et al. (1999)
developed a protocol for the enrichment of rat RGCs based on
magnetic cell separation via inclusion of Thy1+ cells and the
exclusion of macrophages. This method became popular because
it provided a fast method for enrichment of rat RGCs, although
it required magnetic columns and magnetic drivers for the
separation. Unfortunately, their RGC enrichment was only
31% indicating that many contaminating cells are present.
Recently, Hong et al. (2012) combined the immunopanning
and magnetic cell sorter techniques to isolate murine postnatal
(P1–4) RGCs. However, because the success of the method
was based solely on exclusion of glial fibrillary acidic protein
and synthaxin 1, the purity of the RGCs that were isolated is
unknown.
We sought to develop an improved RGC enrichment strategy
that could be used by most investigators without the requirement
for retrograde labeling that may alter the physiology of RGCs.
Our protocol also does not include immunopanning which is
lengthy. Our method is rapid and requires only 5 h from the
initiation of retinal dissection to the completion of fluorescence
activated cell sorting. Because of the exquisite sensitivity of the
method, FACS-based sorting is suited for purification of cells that
comprise a very small percentage within a cell suspension. Thus,
the procedure is ideal for the isolation and enrichment of RGCs,
estimated to be about 0.5% of retinal cells (Dreher et al., 1985;
Jeon et al., 1998). A caveat of ourmethodology is the requirement
of expensive FACS instrumentation, and the need for highly
trained and specialized operator. However, most academic and
research facilities have flow cytometry core facilities, which
should make this method accessible to most investigators. FACS-
based sorting has a tremendous versatility because of the large
number of selection markers that can be used in the enrichment
process. Typically, the selection is based on 2–15 complementary
parameters, which allow for acquisition of a reproducible and
homogeneous phenotype within a sample and between samples
that can be used in follow up in vitro studies. This methodology
also allows for the immediate identification of viable cells and
excludes cells that are undergoing apoptosis or are already dead.
In addition, the inclusion of an Fc receptor blocker allows
for exclusion of microglia, monocytes and macrophages, which
results in a higher degree of RGCs. Lastly, another advantage of
this methodology is the immediate verification of the sort purity,
as it only takes as small aliquot of the isolated product to verify
the surface phenotype.
As part of our RGC enrichment strategy, we incorporated
robust validation components. For example, within our
validation studies, we use IHC to validate two additional
surface markers—CD15 and CD57—that improved the
efficiency of our sorting strategy. In addition, the stringency
of FACS validation strategy was confirmed using four
RGC specific intracellular markers—Sncg, Pouf4l, Tubb3,
and Rbpms, which encode for SNCG, BRN3A, TUJ1, and
RBPMS, respectively—both at the protein and mRNA level.
Furthermore, we identified the presence of non-RGCs
using multiple genes expressed by other retinal cell types
using qPCR analyses. To our knowledge, this is the first
time, such a stringent validation process using both gene
expression (qPCR) and protein (flow cytometry and IHC)
analyses have been performed on isolated and enriched murine
RGCs.
As a further validation of the applicability of our enrichment
protocol, we evaluated the ability of our RGC enrichment
strategy to isolate RGCs from a mouse model with elevated IOP
and optic nerve damage. Members of our collaborative group
use the BXD family of recombinant inbred (RI) mice for gene
mapping and quantitative trait locus (QTL) analyses to identify
specific genomic regions that modulate various glaucoma-
associated endophenotypes (Lu et al., 2011; Swaminathan et al.,
2013; Templeton et al., 2013). The BXD RI strains are derived
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by inbreeding the C57BL/6J and DBA/2J parental strains.
BXD mice have been successfully used in vision research to
elucidate specific cause-effect predictions between genes and
a quantitative phenotype, such as differences in expression
levels (Peirce et al., 2004; Dong et al., 2007; Lu et al., 2008).
In these studies, we selected the BXD66 strain due to its
age-dependent elevation in IOP (Figure 5A) and optic nerve
damage (Figure 5B). Our intracellular flow cytometry protein
analysis revealed a similar percentage of cells that show positivity
for the surface marker Thy1.2, while negative selection of
CD48, CD15 and CD57, and concomitant positivity for the
intracellular markers—SNCG, BRN3A, TUJ1, and RBPMS—in
both C57BL/6J mice and BXD66, irrespective of the age bin
(5 weeks vs. 12 months). Nonetheless, the percentage of RGCs
was significantly lower in the BXD66 mice compared to the
C57BL/6J mice, suggesting that RGCs, a population that is
already scarce in the mammalian retina, is less abundant in
BXD66 mice. Our data also highlight variation in the expression
of TUJ1 in RGCs isolated from BXD66 mice at different ages,
suggesting that differences in TUJ1 levels likely reflect altered
physiology of the damaged RGCs, rather than the absence of
RGCs in these mice.
In summary, we demonstrate a powerful technique for
the isolation and enrichment of primary murine RGC with
the phenotype Live Thy1.2hiCD48negCD15negCD57neg, which
concomitantly express the RGC signature intracellular markers
SNCG, RBPMS, TUJ1, and BRN3A. These cells can be used
for controlled in vitro studies of RGCs derived from healthy
and disease models. The streamlined and effective isolation
and validation method described here will facilitate subsequent
research on the pathological and pharmacological processes with
clinical relevance to diseases involving RGCs.
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Supplementary Figure 1 | Consistency of flow cytometry results.
Dissociated murine retinal cells from C57BL/6J mice were labeled for cell
surface markers as in Figure 3. In contrast to the data presented in
Figures 1, 3, 5, this sample was acquired using a MACSQuantr Analyzer 10
from Miltenyi Biotec. Results show consistency between the two different
cytometers.
Supplementary Figure 2 | Intracellular expression of the RGC marker
RBPMS in Live Thy1.2+ CD48negCD15negCD57neg cells. Representative
images from a cohort of 250,000 pictures at 20× of cells using the
FlowSightr Imager. Results show the localization of Thy1.2 surface and
RBPMS intracellular markers in Live Thy1.2+ CD48negCD15negCD57neg cells.
Supplementary Figure 3 | Live Thy1.2+ CD48negCD15negCD57neg show
RGC morphology. (A) Representative image of sorted cells after being
maintained overnight at 37◦C/5%CO2 in RGC culture media.
(B) Representative images of sorted cells immediately after sort.
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